Katkin Keith bought Syndax Pharmaceuticals ($SNDX) shares once on the open market in the last year, totaling $91,120, with the latest purchase on May 19, 2025. This ranks 2,479th among nearly 5,000 insiders, below the average of 1.5 million per buyer and 3.3 transactions. Keith also sold Emergent BioSolutions ($EBS) shares once for $49,417, most recently on May 23, 2025, ranking 10,409th out of over 11,000 insiders versus an average of 8.6 million per seller and 6.4 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | Syndax Pharmaceuticals Inc | $SNDX | Katkin Keith | Not found | A | Common Stock | 24000 | $0.00 | 124,000.0000 | 86,914,838 | 24.00% | 0.03% |
| Jan. 10, 2026 | Eledon Pharmaceuticals, Inc. | $ELDN | Katkin Keith | Not found | M | Restricted Stock Units | 8575 | $0.00 | 0.0000 | 77,156,068 | 100.00% | 0.01% |
| Jan. 10, 2026 | Eledon Pharmaceuticals, Inc. | $ELDN | Katkin Keith | Not found | M | Common Stock | 8575 | $0.00 | 8,575.0000 | 77,156,068 | 9999.99% | 0.01% |
| May 23, 2025 | Emergent BioSolutions Inc. | $EBS | Katkin Keith | Director | S | Common Stock | 7844 | $6.30 | 86,431.0000 | 53,000,000 | 8.32% | 0.01% |
| May 19, 2025 | Syndax Pharmaceuticals Inc | $SNDX | Katkin Keith | Not found | P | Common Stock | 10000 | $9.11 | 100,000.0000 | 86,024,394 | 11.11% | 0.01% |
| April 30, 2025 | Emergent BioSolutions Inc. | $EBS | Katkin Keith | Director | A | Common Stock | 34403 | $0.00 | 94,275.0000 | 53,000,000 | 57.46% | 0.06% |
| April 30, 2025 | Emergent BioSolutions Inc. | $EBS | Katkin Keith | Director | A | Stock Option (Right to Buy) | 15824 | $0.00 | 41,572.0000 | 53,000,000 | 61.46% | 0.03% |
| Feb. 5, 2025 | Syndax Pharmaceuticals Inc | $SNDX | Katkin Keith | Not found | A | Common Stock | 25000 | $0.00 | 90,000.0000 | 0 | 38.46% | 0.00% |
| Jan. 10, 2025 | Eledon Pharmaceuticals, Inc. | $ELDN | Katkin Keith | Not found | A | Stock Option (right to buy) | 77175 | $0.00 | 77,175.0000 | 48,543,787 | 9999.99% | 0.16% |
| Jan. 10, 2025 | Eledon Pharmaceuticals, Inc. | $ELDN | Katkin Keith | Not found | A | Restricted Stock Units | 8575 | $0.00 | 8,575.0000 | 48,543,787 | 9999.99% | 0.02% |
| May 23, 2024 | Emergent BioSolutions Inc. | $EBS | Katkin Keith | Director | A | Stock Option (Right to Buy) | 25748 | $0.00 | 25,748.0000 | 51,200,000 | 9999.99% | 0.05% |
| May 23, 2024 | Emergent BioSolutions Inc. | $EBS | Katkin Keith | Director | A | Common Stock | 17430 | $0.00 | 59,872.0000 | 51,200,000 | 41.07% | 0.03% |
| Feb. 7, 2024 | Syndax Pharmaceuticals Inc | $SNDX | Katkin Keith | Not found | A | Common Stock | 17000 | $0.00 | 65,000.0000 | 0 | 35.42% | 0.00% |
| May 1, 2023 | Eledon Pharmaceuticals, Inc. | $ELDN | Katkin Keith | Director | A | Stock Option (right to buy) | 752185 | $0.00 | 752,185.0000 | 0 | 9999.99% | 0.00% |
| Feb. 2, 2023 | Syndax Pharmaceuticals Inc | $SNDX | Katkin Keith | Not found | A | Common Stock | 16000 | $0.00 | 48,000.0000 | 0 | 50.00% | 0.00% |
| Feb. 1, 2023 | Eledon Pharmaceuticals, Inc. | $ELDN | Katkin Keith | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |